GAITHERSBURG, Md., Jan. 19, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious ...
(RTTNews) - Novavax Inc. (NVAX) said that Australia's Therapeutic Goods Administration or TGA has granted approval for provisional registration of NVX-CoV2373, Novavax' COVID-19 vaccine (adjuvanted), ...
Nuvaxovid™ is the first protein-based COVID-19 vaccine available for use in adolescents aged 12 through 17 in Australia GAITHERSBURG, Md., July 26, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a ...
Novavax Inc NVAX said Wednesday that Australia’s national drugs regulator has granted approval for its COVID-19 vaccine. What Happened: The Maryland-based biotechnology company said that Australia’s ...
(RTTNews) - Novavax, Inc. (NVAX) announced the Australian Therapeutic Goods Administration has granted provisional registration of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine as a booster in individuals ...
CANBERRA, AustraliaCANBERRA, Australia — Novavax’s COVID-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia. The country has ordered 51 million doses of the U.S.
FILE - In this Wednesday, Oct. 7, 2020, file photo, a vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London. The Novavax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback